Geode Capital Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.38M | Buy |
|
|||||
|
2025
Q1 | $6.85M | Buy |
|
|||||
|
2024
Q4 | $4.61M | Sell |
|
|||||
|
2024
Q3 | $6.06M | Sell |
|
|||||
|
2024
Q2 | $10.9M | Buy |
|
|||||
|
2024
Q1 | $7.75M | Buy |
|
|||||
|
2023
Q4 | $4.46M | Buy |
|
|||||
|
2023
Q3 | $2.47M | Buy |
|
|||||
|
2023
Q2 | $2.38M | Buy |
|
|||||
|
2023
Q1 | $2.98M | Buy |
|
|||||
|
2022
Q4 | $4.9M | Buy |
|
|||||
|
2022
Q3 | $7.71M | Buy |
|
|||||
|
2022
Q2 | $5.06M | Buy |
|
|||||
|
2022
Q1 | $9.4M | Sell |
|
|||||
|
2021
Q4 | $15.6M | Buy |
|
|||||
|
2021
Q3 | $17.2M | Buy |
|
|||||
|
2021
Q2 | $24.7M | Buy |
|
|||||
|
2021
Q1 | $23.4M | Buy |
|
|||||
|
2020
Q4 | $27.6M | Buy |
|
|||||
|
2020
Q3 | $18.6M | Sell |
|
|||||
|
2020
Q2 | $18.7M | Buy |
|
|||||
|
2020
Q1 | $14.2M | Buy |
|
|||||
|
2019
Q4 | $26.6M | Buy |
|
|||||
|
2019
Q3 | $17.1M | Buy |
|
|||||
|
2019
Q2 | $16.7M | Buy |
|
|||||
|
2019
Q1 | $19.9M | Buy |
|
|||||
|
2018
Q4 | $19.5M | Buy |
|
|||||
|
2018
Q3 | $22.9M | Buy |
|
|||||
|
2018
Q2 | $25.2M | Buy |
|
|||||
|
2018
Q1 | $13.1M | Buy |
|
|||||
|
2017
Q4 | $7.19M | Buy |
|
|||||
|
2017
Q3 | $6.38M | Buy |
|
|||||
|
2017
Q2 | $5.35M | Buy |
|
|||||
|
2017
Q1 | $5.39M | Buy |
|
|||||
|
2016
Q4 | $3.46M | Buy |
|
|||||
|
2016
Q3 | $4.39M | Buy |
|
|||||
|
2016
Q2 | $3.95M | Buy |
|
|||||
|
2016
Q1 | $3.94K | Buy |
|
|||||
|
2015
Q4 | $5.47M | Sell |
|
|||||
|
2015
Q3 | $5.15M | Buy |
|
|||||
|
2015
Q2 | $6.17M | Buy |
|
|||||
|
2015
Q1 | $2.16M | Buy |
|
|||||
|
2014
Q4 | $1.26M | Buy |
|
|||||
|
2014
Q3 | $1.03M | Buy |
|
|||||
|
2014
Q2 | $1.35M | Buy |
|
|||||
|
2014
Q1 | $865K | Buy |
|